Long-term use of tirzepatide shows sustained and significant weight loss in adults with overweight or obesity.

Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...

New research being presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that ...

Lebanon: A recent study analyzing data from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) has ...

A MUM has revealed the surprising side benefit of using skinny jabs – and it’s proved just as life-changing as shedding 7st.

Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.

Adults with obesity who used medication and received guidance on resistance training and nutrition lost substantially more ...

A new oral weight loss pill shows results similar to Ozempic and Wegovy injections in the treatment of obesity.

The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...

A DAILY weight loss pill that works like Ozempic has succeeded in a major clinical trial. Patients lost an average of a stone and two pounds (7.3kg) each over 10 months. Unhealthy blood sugar ...

A daily weight loss pill that works like breakthrough fat jab Ozempic could be available in the UK as early as next year.